Tag Archives: Research
Central to the PMI is the All of Us Research Program, which aims to enroll 1 million or more volunteers throughout the United States. If successful, it would be one of the largest longitudinal cohorts ever developed in this country.
February 28, 2017
This post looks at the advantages and disadvantages of the two approaches and discusses how they can be melded to best serve administrative, payment, and research needs.
September 26, 2016
RAND Europe has released a new report on global mental health research funding. The authors have used a "bottom-up" approach that looks at funding acknowledgments by researchers in papers published between 2009 and 2014. The authors analyzed nearly 230,000 papers.
August 16, 2016
In the 25 years since Desert Storm, about 250,000 of the almost 700,000 involved in the Gulf War 1 theater have suffered from some version of Gulf War Illness. Care for these veterans was bedeviled by a lack of understanding of the nature and causes of the illness, and more generally, of the...
August 4, 2016
A recent evaluation of the impact of Texas’ exclusion of Planned Parenthood from a fee-for-service family planning program quickly sparked an aggressive response from state legislators. Placed in the context of increasing polarization, the space for empiricism in debates over politicized health...
June 28, 2016
The discovery of a gene conferring resistance to colistin, a so-called “last resort” antibiotic, has alarmed microbiologists and public health experts around the world. The Senate has the opportunity to pass legislation that would directly address a public health need by bringing drugs for...
April 5, 2016
The CDC is one of the nation’s most powerful voices when it comes to public health recommendations. Unfortunately, its advice on Tamiflu is neither scientifically sound or independently derived. Here we explain why -- and offer suggestions for what to do about it.
March 31, 2016
In a positive first step, the House recently proposed adding Zika to the list of diseases in the Food and Drug Administration’s (FDA) priority review voucher (PRV) program. The PRV platform, however, could be used far more proactively to help address future pandemics before they strike.
March 22, 2016
One of the most important developments in medicine has been an increasing push for transparency about clinical trials and their underlying data. However, there has been heated reaction to more critical views of data sharing.
March 10, 2016
Maternal deaths in the U.S. are on the rise, even as they have declined nearly everywhere else in the world. Women who die from pregnancy or childbirth complications have disproportionately high rates of chronic disease.
February 19, 2016